AHSG
Basic information
Region (hg38): 3:186613060-186621318
Links
Phenotypes
GenCC
Source:
- alopecia-intellectual disability syndrome 1 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Alopecia-intellectual disability syndrome 1 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic; Neurologic | 28054173 |
ClinVar
This is a list of variants' phenotypes submitted to
- Alopecia-intellectual disability syndrome 1 (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AHSG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 25 | 35 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 1 | 0 | 25 | 7 | 13 |
Highest pathogenic variant AF is 0.0000789
Variants in AHSG
This is a list of pathogenic ClinVar variants found in the AHSG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-186613145-A-T | Alopecia-intellectual disability syndrome 1 | Conflicting classifications of pathogenicity (Sep 22, 2024) | ||
3-186613167-G-T | not specified | Uncertain significance (Sep 25, 2023) | ||
3-186613180-C-G | AHSG-related disorder | Benign (Oct 29, 2019) | ||
3-186613222-T-C | Likely benign (Apr 01, 2022) | |||
3-186613230-C-T | not specified | Likely benign (Oct 26, 2021) | ||
3-186613238-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
3-186613258-A-C | not specified | Uncertain significance (Dec 09, 2023) | ||
3-186613349-C-T | Benign (Mar 15, 2018) | |||
3-186614782-G-A | RECLASSIFIED - AHSG POLYMORPHISM | Benign (Jun 01, 2005) | ||
3-186615691-T-C | not specified | Uncertain significance (Oct 26, 2021) | ||
3-186615694-G-A | not specified | Uncertain significance (Nov 09, 2024) | ||
3-186615743-T-G | not specified | Uncertain significance (Mar 06, 2023) | ||
3-186615755-C-A | not specified | Uncertain significance (Mar 29, 2024) | ||
3-186615763-G-A | not specified | Uncertain significance (Mar 21, 2023) | ||
3-186615775-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
3-186617180-C-T | Benign (Mar 29, 2018) | |||
3-186617188-C-G | not specified | Uncertain significance (Mar 28, 2024) | ||
3-186617201-G-T | Benign (Jul 13, 2018) | |||
3-186617245-C-T | Likely benign (Apr 13, 2018) | |||
3-186617249-A-C | not specified | Uncertain significance (Nov 27, 2024) | ||
3-186617268-C-T | not specified | Likely benign (Nov 14, 2024) | ||
3-186617287-C-T | Benign (Dec 31, 2019) | |||
3-186617313-A-G | not specified | Uncertain significance (Jan 13, 2023) | ||
3-186617318-C-G | not specified | Uncertain significance (Dec 09, 2023) | ||
3-186617320-G-C | not specified | Uncertain significance (Nov 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AHSG | protein_coding | protein_coding | ENST00000411641 | 7 | 8396 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.21e-10 | 0.0477 | 125677 | 0 | 71 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.364 | 223 | 208 | 1.07 | 0.0000108 | 2342 |
Missense in Polyphen | 70 | 62.872 | 1.1134 | 734 | ||
Synonymous | 1.17 | 74 | 88.0 | 0.841 | 0.00000511 | 784 |
Loss of Function | -0.266 | 14 | 13.0 | 1.08 | 5.49e-7 | 155 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.000796 | 0.000794 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.000832 | 0.000832 |
European (Non-Finnish) | 0.000291 | 0.000290 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes endocytosis, possesses opsonic properties and influences the mineral phase of bone. Shows affinity for calcium and barium ions.;
- Disease
- DISEASE: Alopecia-mental retardation syndrome 1 (APMR1) [MIM:203650]: A rare autosomal recessive form of alopecia. APMR1 patients show loss of hair on the scalp, absence of eyebrows, eyelashes, axillary and pubic hair, and mild to severe mental retardation. {ECO:0000269|PubMed:28054173}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
- Pathway
- Neutrophil degranulation;Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Innate Immune System;Immune System;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;BMP receptor signaling;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.392
Intolerance Scores
- loftool
- 0.846
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.18
Haploinsufficiency Scores
- pHI
- 0.472
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.596
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ahsg
- Phenotype
- growth/size/body region phenotype; muscle phenotype; homeostasis/metabolism phenotype; skeleton phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype;
Gene ontology
- Biological process
- skeletal system development;ossification;platelet degranulation;pinocytosis;acute-phase response;negative regulation of endopeptidase activity;regulation of bone mineralization;negative regulation of bone mineralization;negative regulation of kinase activity;neutrophil degranulation;post-translational protein modification;cellular protein metabolic process;negative regulation of insulin receptor signaling pathway;regulation of inflammatory response;positive regulation of phagocytosis
- Cellular component
- extracellular region;extracellular space;endoplasmic reticulum lumen;Golgi apparatus;platelet alpha granule lumen;secretory granule lumen;collagen-containing extracellular matrix;extracellular exosome;blood microparticle
- Molecular function
- cysteine-type endopeptidase inhibitor activity;kinase inhibitor activity